Literature DB >> 21490154

Molecular mechanisms of induction of antigen-specific allograft tolerance by intranasal peptide administration.

Katy Derbyshire1, Caroline Addey, David Coe, Daniel W Stuckey, Hasan Muezzin, Jason A Bubier, Daniel J Shaffer, Derry C Roopenian, Jian-Guo Chai, Diane M Scott.   

Abstract

We have previously shown that intranasal (i.n.) administration of a single MHC class II-restricted HY peptide to female mice induces tolerance to up to five additional epitopes expressed on test male grafts, a phenomenon known as linked suppression. In this study, we investigated the molecular mechanisms involved both in the induction phase following peptide administration and during linked suppression after grafting. We report that following initial i.n. administration, peptide is widely disseminated and is presented by functionally immature dendritic cells. These fail to cause optimal stimulation of the responding HY-specific CD4(+) T cells that express genes characteristic of regulatory T cells. Following i.n. peptide plus LPS administration, causing immunization, HY-specific CD4(+) T cells express genes characteristic of activated T cells. We further find that following male skin grafting, HY-specific CD8(+) T cells from peptide-treated tolerant mice display both quantitative and qualitative differences compared with similar cells from untreated mice that reject their grafts. In tolerant mice there are fewer HY-specific CD8(+) cells and they express several genes characteristic of exhausted T cells. Furthermore, associated with specific chemokine receptor and integrin expression, HY-specific CD8(+) T cells show more limited migration from the graft draining lymph node into other tissues.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21490154      PMCID: PMC3321310          DOI: 10.4049/jimmunol.1002444

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  43 in total

1.  Acute rejection in the absence of cognate recognition of allograft by T cells.

Authors:  M Y Braun; I Grandjean; P Feunou; L Duban; R Kiss; M Goldman; O Lantz
Journal:  J Immunol       Date:  2001-04-15       Impact factor: 5.422

2.  Dendritic cells permit identification of genes encoding MHC class II-restricted epitopes of transplantation antigens.

Authors:  D Scott; C Addey; P Ellis; E James; M J Mitchell; N Saut; S Jurcevic; E Simpson
Journal:  Immunity       Date:  2000-06       Impact factor: 31.745

Review 3.  Regulating the immune response to transplants. a role for CD4+ regulatory cells?

Authors:  H Waldmann; S Cobbold
Journal:  Immunity       Date:  2001-04       Impact factor: 31.745

4.  Granzyme B can cause mitochondrial depolarization and cell death in the absence of BID, BAX, and BAK.

Authors:  D A Thomas; L Scorrano; G V Putcha; S J Korsmeyer; T J Ley
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

5.  Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen.

Authors:  O Akbari; R H DeKruyff; D T Umetsu
Journal:  Nat Immunol       Date:  2001-08       Impact factor: 25.606

6.  4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy.

Authors:  J L Cannons; P Lau; B Ghumman; M A DeBenedette; H Yagita; K Okumura; T H Watts
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

7.  TRAF1 is a negative regulator of TNF signaling. enhanced TNF signaling in TRAF1-deficient mice.

Authors:  E N Tsitsikov; D Laouini; I F Dunn; T Y Sannikova; L Davidson; F W Alt; R S Geha
Journal:  Immunity       Date:  2001-10       Impact factor: 31.745

8.  Estimating the precursor frequency of naive antigen-specific CD8 T cells.

Authors:  Joseph N Blattman; Rustom Antia; David J D Sourdive; Xiaochi Wang; Susan M Kaech; Kaja Murali-Krishna; John D Altman; Rafi Ahmed
Journal:  J Exp Med       Date:  2002-03-04       Impact factor: 14.307

9.  Regulatory T cells inhibit dendritic cells by lymphocyte activation gene-3 engagement of MHC class II.

Authors:  Bitao Liang; Craig Workman; Janine Lee; Claude Chew; Benjamin M Dale; Lucrezia Colonna; Marcella Flores; Nianyu Li; Edina Schweighoffer; Steven Greenberg; Victor Tybulewicz; Dario Vignali; Raphael Clynes
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422

10.  Initiation of apoptosis by granzyme B requires direct cleavage of bid, but not direct granzyme B-mediated caspase activation.

Authors:  V R Sutton; J E Davis; M Cancilla; R W Johnstone; A A Ruefli; K Sedelies; K A Browne; J A Trapani
Journal:  J Exp Med       Date:  2000-11-20       Impact factor: 14.307

View more
  4 in total

1.  Strain-specific variation in murine natural killer gene complex contributes to differences in immunosurveillance for urethane-induced lung cancer.

Authors:  Daniel Kreisel; Andrew E Gelman; Ryuji Higashikubo; Xue Lin; Haris G Vikis; J Michael White; Kelsey A Toth; Charuhas Deshpande; Beatriz M Carreno; Ming You; Samantha M Taffner; Wayne M Yokoyama; Jack D Bui; Robert D Schreiber; Alexander S Krupnick
Journal:  Cancer Res       Date:  2012-06-29       Impact factor: 12.701

2.  Role of dendritic cell maturity/costimulation for generation, homeostasis, and suppressive activity of regulatory T cells.

Authors:  Katrien Pletinckx; Anja Döhler; Vladimir Pavlovic; Manfred B Lutz
Journal:  Front Immunol       Date:  2011-09-27       Impact factor: 7.561

3.  Integrin CD11b positively regulates TLR4-induced signalling pathways in dendritic cells but not in macrophages.

Authors:  Guang Sheng Ling; Jason Bennett; Kevin J Woollard; Marta Szajna; Liliane Fossati-Jimack; Philip R Taylor; Diane Scott; Guido Franzoso; H Terence Cook; Marina Botto
Journal:  Nat Commun       Date:  2014       Impact factor: 14.919

4.  Intranasal peptide-induced tolerance and linked suppression: consequences of complement deficiency.

Authors:  Liliane Fossati-Jimack; Guang Sheng Ling; Lucie Baudino; Marta Szajna; Kiruthika Manivannan; Jade Chen Zhao; Robert Midgley; Jian-Guo Chai; Elizabeth Simpson; Marina Botto; Diane Scott
Journal:  Immunology       Date:  2015-01       Impact factor: 7.397

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.